1-2 of 2
Fergus Cafferty
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma

Clinical Trials & Observations Brief Report
Ciara L. Freeman, Robert Kridel, Alden A. Moccia, Kerry J. Savage, Diego R. Villa, David W. Scott, Alina S. Gerrie, David Ferguson, Fergus Cafferty, Graham W. Slack, Pedro Farinha, Brian Skinnider, Joseph M. Connors, Laurie H. Sehn
Journal: Blood
Blood (2019) 134 (9): 761–764.
https://doi.org/10.1182/blood.2019000258
Published: 2019
Includes: Supplemental data
Journal Articles

Frontline Therapy with Bendamustine and Rituximab (BR) in Follicular Lymphoma: Prognosis Among Patients with Progression of Disease By 24 Months (POD24) Is Poor with Majority Having Transformed Lymphoma

Ciara Louise Freeman, MRCP, MSc, FRCPath, MBBChir, Kerry J Savage, BSc, MD MSc, Diego Villa, MD, David W. Scott, PhDMD, FRACP, FRCPA, Alina S. Gerrie, MD MPH, David J Ferguson, Fergus Cafferty, Graham W Slack, MD, Pedro Farinha, MD PhD, Brian Skinnider, Joseph M. Connors, MD, Laurie H Sehn, MD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 2873.
https://doi.org/10.1182/blood-2018-99-113675
Published: 2018